Imodium and Psyllium husk drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Imodium (loperamide hydrochloride) and Psyllium husk (blond psyllium). Common drug interactions include abdominal discomfort among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Imodium and Psyllium husk. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Imodium?

Imodium has active ingredients of loperamide hydrochloride. It is often used in diarrhea. eHealthMe is studying from 45,092 Imodium users. Check the latest studies of Imodium.

What is Psyllium husk?

Psyllium husk has active ingredients of blond psyllium. It is often used in constipation. eHealthMe is studying from 1,493 Psyllium husk users. Check the latest studies of Psyllium husk.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Jul, 04, 2026

23 people who take Imodium and Psyllium husk together, and have interactions are studied.

Imodium and Psyllium husk drug interactions.

What are the common drug interactions of Imodium and Psyllium Husk, by gender? *:

female:

  1. Abdominal discomfort
  2. Drug hypersensitivity
  3. Food allergy
  4. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Bacteriuria (presence of bacteria in urine)
  7. Chronic kidney disease
  8. Drug ineffective
  9. Dyspnoea (difficult or laboured respiration)
  10. Epistaxis (bleed from the nose)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Blood pressure decreased
  3. Fall
  4. Head injury
  5. Hospitalisation
  6. Pneumonia
  7. Renal disorder (kidney disease)
  8. Syncope (loss of consciousness with an inability to maintain postural tone)
  9. Bradycardia (abnormally slow heart action)
  10. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

What are the common drug interactions of Imodium and Psyllium Husk, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Bacteriuria (presence of bacteria in urine)
  2. Chronic kidney disease
  3. Hyperchromic anaemia (anaemia in which the red blood cells (erythrocytes) are paler than normal)
  4. Hyperkalaemia (damage to or disease of the kidney)
  5. Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
  6. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  7. Hypokalaemia (low potassium)
  8. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  9. Hypotension (abnormally low blood pressure)
  10. Magnesium deficiency (lack of magnesium)

50-59:

n/a

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Abdominal discomfort
  3. Oxygen saturation decreased
  4. Pulmonary arterial pressure increased
  5. Somnolence (a state of near-sleep, a strong desire for sleep)
  6. Weight decreased
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Dehydration (dryness resulting from the removal of water)
  9. Drug ineffective
  10. Epistaxis (bleed from the nose)

What are the existing conditions these people have? *

  1. Pain: 7 people, 30.43%
  2. Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 4 people, 17.39%
  3. Urinary Tract Infection: 4 people, 17.39%
  4. Rashes (redness): 3 people, 13.04%
  5. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 8.70%
  6. Hypokalemia (low potassium): 2 people, 8.70%
  7. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 8.70%
  8. Cough: 2 people, 8.70%
  9. Drowsiness: 2 people, 8.70%
  10. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Imodium and Psyllium husk?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Imodium and Psyllium husk:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Imodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Psyllium husk:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Imodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Psyllium husk and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on loperamide hydrochloride and blond psyllium (the active ingredients of Imodium and Psyllium husk, respectively), and Imodium and Psyllium husk (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: